Brightsurf Science News & Current Events

December 02, 2018
Epileptics in high-crime neighborhoods have three times as many seizures
People with epilepsy living in high crime neighborhoods in Chicago had three times as many seizures as those living in neighborhoods with lower crime rates according to new research from the University of Illinois at Chicago presented at the American Epilepsy Society 2018 conference in New Orleans.

Baby's first cold can last longer depending on nose-dwelling bacteria
New research on the types of bacteria living in babies' noses could offer clues as to why some recover quickly from their first cough or cold, while others suffer for longer.

Cleveland Clinic's Aziz Nazha, M.D., develops personalized prediction model for patients with MDS
At the American Society of Hematology (ASH) Annual Meeting, Cleveland Clinic medical hematologist and oncologist Aziz Nazha, M.D., will present results of a personalized prediction model that surpassed current prediction models for Myelodysplastic Syndromes (MDS).

Women reveal the reasons they reject a preventive drug for breast cancer
Only around a fifth of women at higher risk of developing breast cancer think they need to take a drug proven to help prevent the disease, according to new research funded by Cancer Research UK and published today in Clinical Breast Cancer.

More than half of patients alive two years after receiving CAR-T therapy for diffuse large B-cell lymphoma in ZUMA-1 trial
A follow-up analysis of patients enrolled in a Phase I/II multi-center trial for diffuse large B-cell lymphoma (DLBCL) reported 51 percent of patients receiving an anti-CD19 chimeric antigen receptor (CAR T) called axi-cel were still alive two years post-treatment.

Saltier waterways are creating dangerous 'chemical cocktails'
New research suggests that saltier, more alkaline freshwater can release toxic metals and harmful nitrogen-containing compounds from streambeds and soils in drainage basins.

Wild yeasts may hold key to better wines from warmer climates
Researchers at the University of Adelaide have found yeasts that naturally occur on wine grapes may improve wines produced in warmer climates.

Dana-Farber researchers report clinical trial results in treatment of leukemia & lymphoma
New results from clinical trials of immunotherapy and experimental targeted agents for patients with leukemia and lymphoma are being presented by Dana-Farber Cancer Institute researchers at the ASH Annual Meeting.

New two-year data show 39 percent of NHL patients treated with CAR T remain in remission
A new article published today in The Lancet Oncology shows 39 percent of large B cell lymphoma patients treated with the chimeric antigen receptor T-cell therapy (CAR T) Yescarta® (axicabtagene ciloleucel) remained in remission more than two years (27.1 months median follow up) following therapy, and more than half of the patients treated remain alive.
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.